Chapter 3 62 34. van den Born J, van den Heuvel LP, Bakker MA, Veerkamp JH, Assmann KJ, Weening JJ, and Berden JH. Distribution of GBM heparan sulfate proteoglycan core protein and side chains in human glomerular diseases. Kidney international 43: 454-463, 1993. 35. van Det NF, van den Born J, Tamsma JT, Verhagen NA, Berden JH, Bruijn JA, Daha MR, and van der Woude FJ. Effects of high glucose on the production of heparan sulfate proteoglycan by mesangial and epithelial cells. Kidney international 49: 1079-1089, 1996. 36. van Eeden FJ, Granato M, Schach U, Brand M, Furutani-Seiki M, Haffter P, Hammerschmidt M, Heisenberg CP, Jiang YJ, Kane DA, Kelsh RN, Mullins MC, Odenthal J, Warga RM, and Nusslein-Volhard C. Genetic analysis of fin formation in the zebrafish, Danio rerio. Development 123: 255-262, 1996. 37. Wiweger MI, Avramut CM, de Andrea CE, Prins FA, Koster AJ, Ravelli RB, and Hogendoorn PC. Cartilage ultrastructure in proteoglycan-deficient zebrafish mutants brings to light new candidate genes for human skeletal disorders. The Journal of pathology 223: 531-542, 2011. 38. Wiweger MI, Zhao Z, van Merkesteyn RJ, Roehl HH, and Hogendoorn PC. HSPG-deficient zebrafish uncovers dental aspect of multiple osteochondromas. PloS one 7: e29734, 2012.
RkJQdWJsaXNoZXIy MTk4NDMw